About Sedivention
Sedivention is a company based in Munchen (Germany) founded in 2021 by Ute Nollert. Sedivention has raised $843.06 thousand across 2 funding rounds from investors including High-Tech Gründerfonds. Sedivention offers products and services including Blizzard Catheter. Sedivention operates in a competitive market with competitors including Allurion, Apollo Endo, GT Metabolic Solutions, IG Balloon and Spatz FGIA, among others.
- Headquarter Munchen, Germany
- Founders Ute Nollert
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sedivention Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$843.06 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sedivention
Sedivention offers a comprehensive portfolio of products and services, including Blizzard Catheter.
Performs cryo-ablation to reduce hunger feeling for long-term obesity management.
Funding Insights of Sedivention
Sedivention has successfully raised a total of $843.06K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sedivention
Sedivention has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked |
Investor details for Sedivention
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sedivention
Investment portfolio details for Sedivention
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sedivention
Detailed financials for Sedivention
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sedivention Comparisons
Peer comparison for Sedivention
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sedivention
Sedivention operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allurion, Apollo Endo, GT Metabolic Solutions, IG Balloon and Spatz FGIA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
|
|
| Locked | Locked | Locked |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| Locked | Locked | Locked |
Incision-less bariatric surgery technology is developed for gastric bypass.
|
|
| Locked | Locked | Locked |
Offers updates on medical device designs and clinical trial outcomes.
|
|
| Locked | Locked | Locked |
Minimally invasive gastric balloon is developed for obesity satiety induction.
|
Detailed competitors of Sedivention
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sedivention
Complete news archive for Sedivention
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sedivention
Sedivention was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Sedivention is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Ute Nollert is the current CEO of Sedivention. They have also founded this company.
Sedivention is a funded company, having raised a total of $843.06K across 2 funding rounds to date.
Sedivention was founded in 2021 in Munich, Germany, focusing on medical devices in the health technology sector. A minimally invasive outpatient procedure using cryo-ablation is being developed to target the gastric branches of the vagus nerve, thereby reducing hunger signals for long-term weight management. The associated device has undergone testing for safety and efficacy, with backing from awards and investments in the European market.
Sedivention's top competitors include Allurion, Apollo Endo and GT Metabolic Solutions.
Sedivention offers Blizzard Catheter.
Sedivention has 1 investor. Key investors include High-Tech Gründerfonds.